M. P. Glauser

2.0k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

M. P. Glauser is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, M. P. Glauser has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 10 papers in Infectious Diseases and 5 papers in Pharmacology. Recurrent topics in M. P. Glauser's work include Antimicrobial Resistance in Staphylococcus (7 papers), Infective Endocarditis Diagnosis and Management (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). M. P. Glauser is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Infective Endocarditis Diagnosis and Management (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). M. P. Glauser collaborates with scholars based in Switzerland, United States and Netherlands. M. P. Glauser's co-authors include J. D. Baumgartner, Paul‐Henri Lambert, J. Verhoef, J. F. P. Schellekens, Georges E. Grau, Thierry Calandra, Lawrence R. Freedman, E Héraïef, Didier Heumann and Jean-Daniel Baumgartner and has published in prestigious journals such as The Lancet, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

M. P. Glauser

21 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

1990 428 citations Thierry Calandra, J. D. Baumgartner et al. The Journal of Infectious Diseases profile →

Peers

Countries citing papers authored by M. P. Glauser

Since Specialization

Citations

This map shows the geographic impact of M. P. Glauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. P. Glauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. P. Glauser more than expected).

Fields of papers citing papers by M. P. Glauser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. P. Glauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. P. Glauser. The network helps show where M. P. Glauser may publish in the future.

Co-authorship network of co-authors of M. P. Glauser

This figure shows the co-authorship network connecting the top 25 collaborators of M. P. Glauser. A scholar is included among the top collaborators of M. P. Glauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. P. Glauser. M. P. Glauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beta-2-Microglobulin in Acquired Immune Deficiency Syndrome 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·P Francioli, (unknown), Bertrand Yersin, (unknown), M. P. Glauser	0
2	Dual Microsporidial Infection Due to Vittaforma corneae and Encephalitozoon hellem in a Patient with AIDS 1998 ·Clinical Infectious Diseases ·P. Deplazes, Alexander Mathis, (unknown), Anne Iten, (unknown), I. Tanner, M. P. Glauser, Rainer Weber, Elizabeth U. Canning	25
3	Anticytokine Strategies for the Treatment of Septic Shock: Relevance of Animal Models 1996 ·Current topics in microbiology and immunology ·Didier Heumann, M. P. Glauser	22
4	Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis 1995 ·Médecine et Maladies Infectieuses ·(unknown), Ursula Flückiger, M. P. Glauser, P. Moreillon	1
5	Bactericidal/Permeability-Increasing Protein Inhibits Induction of Macrophage Nitric Oxide Production by Lipopolysaccharide 1994 ·The Journal of Infectious Diseases ·Sally Betz Corradin, Didier Heumann, Philippe Gallay, (unknown), Jacques Mauël, M. P. Glauser	25
6	Antibiotic Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus epidermidis 1994 ·The Journal of Infectious Diseases ·(unknown), Ursula Flückiger, M. P. Glauser, P. Moreillon	21
7	Short time exposure to lipopolysaccharide is sufficient to activate human monocytes 1993 ·The Journal of Immunology ·Philippe Gallay, C. Victor Jongeneel, C Barras, Miguel N. Burnier, J. D. Baumgartner, M. P. Glauser, Didier Heumann	99
8	Incidence of gallbladder lithiasis after ceftriaxone treatment 1990 ·Journal of Antimicrobial Chemotherapy ·Alain Cometta, (unknown), Anne Iten, L Cantoni, (unknown), J.-J. Gonvers, M. P. Glauser	17
9	Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock breakdown → 1990 ·The Journal of Infectious Diseases ·Thierry Calandra, J. D. Baumgartner, Georges E. Grau, (unknown), Paul‐Henri Lambert, J. F. P. Schellekens, J. Verhoef, M. P. Glauser, (unknown)	428
10	From the Immunocompromised Host Society: The Design, Analysis, and Reporting of Clinical Trials on the Empirical Antibiotic Management of the Neutropenic Patient: Report of a Consensus Panel 1990 ·The Journal of Infectious Diseases ·P. A. Pizzo, D. Armstrong, Gerald P. Bodey, Ben de Pauw, Ronald Feld, M. P. Glauser, H. Gaya, Judith E. Karp, (unknown), G Todeschini, J. Verhoef, James C. Wade, Lawrence S. Young, J. Remington	230
11	Immunotherapy of gram-negative infections in oncological patients 1989 ·European Journal of Cancer and Clinical Oncology ·M. P. Glauser	1
12	Predictors of Endocarditis in Isolates from Cultures of Blood Following Dental Extractions in Rats with Periodontal Disease 1988 ·The Journal of Infectious Diseases ·Philippe Moreillon, C. Daniel Overholser, R Malinverni, Jacques Billé, M. P. Glauser	37
13	SIDA: L'information comme outil de prévention 1986 ·Sozial- und Präventivmedizin ·Dominique Hausser, (unknown), Bernard Burnand, M. P. Glauser, Félix Gutzwiller	0
14	PREVENTION OF GRAM-NEGATIVE SHOCK AND DEATH IN SURGICAL PATIENTS BY ANTIBODY TO ENDOTOXIN CORE GLYCOLIPID 1985 ·The Lancet ·Jean-Daniel Baumgartner, J. Allen McCutchan, Guy van Melle, Markus Vogt, Ruedi Luethy, M. P. Glauser, (unknown), (unknown), (unknown), René Chiolero, Stefanos Geroulanos	292
15	Immunoprophylaxis and Immunotherapy of Gram-negative Infections in the Immunocompromised Host 1984 ·Clinics in Haematology ·M. P. Glauser, J. Allen McCutchan, E. J. Ziegler	0
16	Comparative imipenem treatment of Staphylococcus aureus endocarditis in the rat 1983 ·Journal of Antimicrobial Chemotherapy ·J. D. Baumgartner, M. P. Glauser	11
17	Comparative study of imipenem in severe infections 1983 ·Journal of Antimicrobial Chemotherapy ·J. D. Baumgartner, M. P. Glauser	33
18	Treatment of Experimental Ascending <i>Escherichia coli</i> Pyelonephritis with Ceftriaxone Alone and in Combination with Gentamicin 1982 ·Chemotherapy ·M. P. Glauser, (unknown)	12
19	Effect of nitrogen mustard on natural history of right-sided streptococcal endocarditis in rabbits: role for cellular host defenses 1982 ·Infection and Immunity ·Bertrand Yersin, M. P. Glauser, Lawrence R. Freedman	22
20	[Fulminant pneumococcal septicemia in splenectomized patients]. 1981 ·PubMed ·P Francioli, Marie‐Denise Schaller, M. P. Glauser	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact